Detalhe da pesquisa
1.
Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States.
Cancer
; 127(4): 609-618, 2021 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33085090
2.
Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection.
Ann Hematol
; 100(1): 37-43, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-32918594
3.
Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries.
Biol Blood Marrow Transplant
; 26(2): 333-342, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31563573
4.
Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.
Biol Blood Marrow Transplant
; 25(1): 73-85, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30153491
5.
Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.
Biol Blood Marrow Transplant
; 22(2): 248-257, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26327629
6.
The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia.
Biol Blood Marrow Transplant
; 21(7): 1251-7, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-25840335
7.
Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial.
Biol Blood Marrow Transplant
; 21(10): 1815-22, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26071866
8.
Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.
Biol Blood Marrow Transplant
; 21(3): 552-8, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25528388
9.
The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen.
Biol Blood Marrow Transplant
; 21(10): 1746-53, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25981509
10.
Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.
Biol Blood Marrow Transplant
; 21(2): 266-74, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25445023
11.
Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
Br J Haematol
; 171(4): 585-94, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26223288
12.
Survival improvements in adolescents and young adults after myeloablative allogeneic transplantation for acute lymphoblastic leukemia.
Biol Blood Marrow Transplant
; 20(6): 829-36, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24607554
13.
Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: comparison among alternative graft sources.
Biol Blood Marrow Transplant
; 20(11): 1819-27, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25064747
14.
Does total body irradiation conditioning improve outcomes of myeloablative human leukocyte antigen-identical sibling transplantations for chronic lymphocytic leukemia?
Biol Blood Marrow Transplant
; 20(3): 421-4, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-24321745
15.
Outcomes of human leukocyte antigen-matched sibling donor hematopoietic cell transplantation in chronic lymphocytic leukemia: myeloablative versus reduced-intensity conditioning regimens.
Biol Blood Marrow Transplant
; 20(9): 1390-8, 2014 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-24880021
16.
Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research.
Biol Blood Marrow Transplant
; 20(1): 89-97, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24161923
17.
Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma.
Biol Blood Marrow Transplant
; 20(7): 951-9, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-24641828
18.
Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival.
Biol Blood Marrow Transplant
; 20(7): 960-8, 2014 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-24641829
19.
Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation.
Biol Blood Marrow Transplant
; 20(11): 1729-36, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25008330
20.
Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease.
Haematologica
; 104(12): e543-e546, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31018975